MENODYS announces the addition of 2 new features to its Tinnitus Assessment Technology

Longueuil, Quebec, Canada – MENODYS in collaboration with Pr. Sylvie Hébert of the School of Speech Pathology and Audiology at the University of Montreal announce the addition of new features to its Tinnitus Assessment Technology (TAT), an extension module to assess the Minimum Masking Level and an extension module to assess Residual Inhibition.

“The addition of these 2 new features to the already available Pitch and Loudness features offers a complete all-in-one solution for the objective assessment of tinnitus”, said Richard Côté, Executive Vice President of MENODYS.

“The Tinnitus Assessment Technology offers, to audiology clinicians around the world, a new mean to rapidly and objectively assess tinnitus, prescribe the best tinnitus symptoms attenuation protocol for their patients and finally follow up on the benefits of the symptoms attenuation protocol in reducing the effects of tinnitus over time ”, said Pr. Hébert.

Tinnitus is an important and growing worldwide health issue in audiology affecting more than 30 million Americans and more than 120 million Europeans.

MENODYS is a Canadian company specialized in the development and commercialization of medical technologies.